Skip to main content
. Author manuscript; available in PMC: 2016 Jul 1.
Published in final edited form as: J Infect Chemother. 2015 Mar 20;21(7):507–511. doi: 10.1016/j.jiac.2015.03.007

Table 2.

Patient characteristics of obese versus non-obese patients (N = 108)

Obese
(n=37)
Non-Obese
(n=71)
P-value
Age, mean (SD) 59.3 (14.0) 59.6 (15.4) 0.27
Male, n (%) 13 (35.1) 54 (76.1) < 0.001
Ethnicity, n (%) 0.70
  Caucasian 4 (10.8) 6 (8.5)
  African American 29 (78.4) 53 (74.6)
  Asian 0 (0) 3 (4.2)
  Hispanic 3 (8.1) 8 (11.3)
  Other 1 (2.7) 1 (1.4)
Total body weight (kg), mean (SD) 106.2 (20.8) 71.9 (13.3) < 0.001
Body mass index (kg/m2), mean (SD) 36.7 (6.4) 23.9 (3.1) < 0.001
Comorbidities, n (%)
  Diabetes 16 (43.2) 18 (25.4) 0.057
  Hypertension 24 (64.9) 41 (57.7) 0.47
  Heart failure 2 (5.4) 1 (1.4) 0.27
  Ascites 0 (0) 1 (1.4) 1.00
Concurrent nephrotoxins, mean (SD) 1.0 (1.1) 1.1 (1.1) 0.65
Type of Infection, n (%)
  Bloodstream 3 (8.1) 7 (9.9) 1.00
  Lungs 15 (40.5) 30 (42.3) 0.86
  Cerebrospinal fluid 1 (2.7) 4 (5.6) 0.66
  Urinary tract 1 (2.7) 5 (7.0) 0.66
  Bone 8 (21.6) 12 (16.9) 0.55
  Skin 1 (2.7) 1 (1.4) 1.00
  Neutropenic fever 0 (0) 3 (4.2) 0.55
  Sepsis 21 (56.8) 42 (59.2) 0.63
Renal function, mean (SD)
  Baseline serum creatinine (mg/dL) 0.99 (0.31) 0.94 (0.21) 0.52
  End serum creatinine (mg/dL) 0.94 (0.22) 0.92 (0.22) 0.31
  Baseline creatinine clearance (mL/min) 86.2 (24.6) 82.0 (25.6) 0.34
  End creatinine clearance (mL/min) 89.2 (24.4) 84.3 (26.3) 0.35
APACHE II* Score, mean (SD) 12.7 (8.4) 13.4 (7.5) 0.39
SOFA*Score, mean (SD) 3.0 (2.8) 3.3 (1.9) 0.07
*

Abbreviations: APACHE II = Acute Physiology And Chronic Health Evaluation II; SOFA = Sequential Organ Failure Assessment